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Introduction
The care of cancer patients has been made much easier
by the widespread use of a totally implantable venous
access system (Port-A catheter) for chemotherapy.
Major complications that may occur with Port-A
catheters include thrombosis, infection, extravasation
of the administered agents, fracture of the catheter,
and migration of the catheter.1,2 Even though Port-A
catheter materials have improved greatly, the develop-
ment of thromboses of the superior vena cava, sub-
clavian vein, or axillary vein is still a serious problem.
Clinical evidence of venous obstruction occurs in
3–40% of patients with central venous catheters.3
Specifically, with a subclavian Port-A catheter, throm-
botic occlusion occurs in up to 25% of patients.4
The major diagnostic procedures for catheter-
associated thromboses are contrast or digital subtraction
venography, Doppler ultrasonography, and computed
tomography (CT). Although upper extremity radio-
nuclide venography has been reported to be a valuable
modality for venous thrombosis of the upper extremi-
ties,5 the application of this simple procedure specifi-
cally for thrombosis associated with Port-A catheters
has not been reported. We investigated the potential
role of radionuclide venography with a dynamic flow
study, in the clinical assessment of upper extremity
venous return for patients with a Port-A catheter.
Methods
Between June 2004 and June 2005, a study with upper
extremity radionuclide venography was conducted in
cancer patients with a Port-A catheter at a regional
teaching hospital. The patients included in this study
ORIGINAL ARTICLE
Application of Upper Extremity Radionuclide
Venography as a Diagnostic Approach for 
Port-A Catheter Thrombosis
Yuh-Feng Wang1,3*, Shiou-Chi Cherng4, Jainn-Shiun Chiu1,3, Yu-Cheih Su2,3, Yu-Tsan Sheu2,3
1Department of Nuclear Medicine, and 2Section of Hematology-Oncology, Department of Internal Medicine, 
Buddhist Dalin Tzu Chi General Hospital, Chiayi, and 3Department of Medicine, Tzu Chi University, 
Hualien, and 4Tri-Service General Hospital, Taipei, Taiwan, R.O.C.
Background: To investigate the role of upper extremity radionuclide venography as a potential diagnostic modality in the
assessment of venous thrombosis associated with a Port-A catheter.
Methods: Fourteen symptomatic patients who had received Port-A catheter implantation were enrolled. A dynamic nuclear
medicine flow study was performed with intravenous administration of Technetium-99m macroaggregated albumin to both
upper extremities. Imaging patterns of the venous system were categorized as patency, partial obstruction, and total occlusion. 
Results: The findings of the dynamic images clearly demonstrated clinical problems. Three patients were free of a defi-
nite venous flow change. Three patients had partial obstruction of venous return. A significant cut-off of venous return
was demonstrated in 8 patients, and total occlusions were hence diagnosed. All patients underwent this procedure
smoothly without any complication. 
Conclusion: These results suggest that upper extremity radionuclide venography is an easily performed and effective
method for diagnosing Port-A catheter thrombosis in clinical practice. [J Chin Med Assoc 2006;69(8):358–363]
Key Words: radionuclide angiography, thrombosis, upper extremity, vascular access port 
J Chin Med Assoc • August 2006 • Vol 69 • No 8 359
Radionuclide venography for Port-A catheter thrombosis
exhibited 1 or more of the following: a decreased
Port-A catheter flow rate; difficulty with infusing solu-
tions; superior vena cava syndrome; ipsilateral pain,
edema, or venous engorgement. Patients with upper
extremity thrombophlebitis, varicose veins, and/or
receiving anticoagulation therapy were excluded from
this study. All patients were investigated in the same
department. Since radionuclide venography displays
higher sensitivity and specificity compared to magnetic
resonance imaging (MRI) or venography for detecting
upper extremity and catheter-related thromboses,6,7 our
hospital policy allows the use of radionuclide veno-
graphy for evaluating the possibility of thrombosis in
these patients. Therefore, ultrasonography, MRI, or
contrast venography was not performed concurrently
with this study. The Ethics Committee on Human
Studies at our hospital approved the study, and this
investigation was conducted according to the guide-
lines of the Declaration of Helsinki.
No specific preparation for enrolled patients was
required prior to this examination. The blood flows in
the deep venous system from the upper extremities to
the heart were evaluated noninvasively using radio-
nuclide venography. All images were acquired using
dual-head gamma camera analysis (DST-XLi, General
Electric Medical Systems, Buc, France) equipped with
large-field-of-view, low-energy, general-all-purpose col-
limators with a 20% energy window centered at 140
KeV. With the patient supine, an intravenous line was
applied to a superficial dorsal vein of the Port-A catheter
ipsilateral hand through a 23-gauge 3/4-inch butterfly
needle. A 3-way stopcock was attached to the tubing
system. A superficial dorsal vein in the contralateral
hand was accessed as well to determine the patency of
the superior vena cava. The contralateral injection of
radiotracer also helped to assess the venous anatomy on
that side in case the Port-A catheter was to be replaced.
At the beginning of this procedure, 185 MBq (5mCi)
Technetium-99m macroaggregated albumin (Tc-99m
MAA) was administrated as a bolus injection simultane-
ously to both sites followed by 10 mL of normal saline
flush to each stopcock. Concurrently with the radio-
tracer injection, we acquired dynamic images on a work-
station computer at a rate of 0.4 seconds/frame for 300
seconds. The region of interest selected was from the
lower neck over the anterior chest and shoulders to 
the lung base, with the heart in the lower 1-third of 
the field of view. The images were visually interpreted
for the deep venous flow from the upper extremities
bilaterally to the heart by an experienced nuclear medi-
cine physician who was not aware of the patients’
clinical conditions. The ipsilateral flow was compared
with the contralateral flow. Scintigraphic diagnosis was
made by the imaging patterns. Three major categories
were accepted as a diagnosis due to the Port-A catheter.
1. Patency of venous return: symmetric, smooth, and
continuous flow in the deep venous system from
the upper extremities to the heart. No remarkable
delayed passage or stasis of the radiotracer found
(Figure 1).
2. Partial obstruction of venous return: images showed
significant delayed dissipation of radiotracer in com-
parison with the contralateral site even though the
radiotracer was subsequently cleared (Figure 2).
3. Total occlusion of venous return: truncated venous
return of the deep venous system at the ipsilateral
site (Figure 3) or retrograde flow to the jugular
vein (Figure 4) was demonstrated.
Results
A total of 14 cancer patients (11 males and 3 females,
aged 58.3 ± 3.8, range 34–78 years) with a Port-A
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Figure 1. A Port-A catheter was implanted in a 73-year-old male with lung cancer for long-term therapy (patient 9). Upper extremity
radionuclide venography was performed for the clinical complaint of swelling sensation in his left upper arm. Scintigraphic images
clearly displayed the flow of radiotracer from the upper extremities, subclavian vein, superior vena cava, right heart, and then bilateral
lung fields. No definite disruption of venous return was demonstrated. The scintigraphic result essentially excluded the possibility of
venous obstruction in the upper extremities.
catheter were enrolled. The basic and resulting char-
acteristics of enrolled patients are presented in Table 1.
A diagnosis of patency of venous return was found in
3 patients (21%). A decreased flow rate with a diagno-
sis of partial obstruction of venous return was found
in 3 patients (21%). Significant cut-off or truncated
venous return was demonstrated in 8 patients (57%)
who were diagnosed as having total occlusion of
venous return. In the subgroup with total occlusion
of venous return, patients were grouped according to
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Figure 2. This was a 55-year-old male with oral cancer (patient 2). Upper extremity radionuclide venography was performed for the clin-
ical complaint of swelling sensation in his left upper arm. In comparison with the venous return of the right site, the radiotracer from the
left upper arm showed a significant delay. A section with diminished radioactivity was found in the left subclavian vein (arrows).
However, continuous flow could be found. This finding was suggestive of a partial obstruction of venous return caused by compression
of the Port-A catheter.
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Figure 4. Upper extremity radionuclide venography was performed in a 69-year-old male with colon cancer (patient 11). In addition to the
major cut-off sign of venous return in the left subclavian vein, obvious regurgitation of radiotracer in the jugular veins was also demonstrated.
About 6–8 frames later (2.4–3.2 seconds), radiotracer flow was found in the counter site of neck. This finding exhibited total occlusion of the
left subclavian vein. Venous return was retrogradely forced to the left jugular vein, passing the skull base area, joining the right jugular vein
and returning to the superior vena cava.
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Figure 3. A 71-year-old male with bladder cancer received Port-A catheter implantation for long-term chemotherapy (patient 13). Upper extrem-
ity radionuclide venography was carried out for edema of the upper arm. Major cut-off sign was demonstrated in the left subclavian vein
(arrows). This finding indicated total occlusion of the left subclavian vein. Local background activity around the left supraclavical area was 
elevated, which was suggestive of microcirculation.
the type of abnormal flow. Evidence of collateral cir-
culation was demonstrated in 5 patients. Retrograde
flow in the ipsilateral jugular vein that forced the
radiotracer to bypass the skull base, move to the con-
tralateral jugular vein, the superior vena cava, and
finally enter the right heart was found in 2 patients.
Another patient presented a cut-off of the left subcla-
vian vein and showed venous shunt flow directly to
the pulmonary vessels. All patients underwent the
procedure smoothly, and no complication occurred as
a result of the procedure.
Discussion
A number of different types of devices and sites for
the implantation of venous access systems have been
increasingly utilized in various conditions in daily prac-
tice. Tunneled percutaneous placement of silicone
rubber-cuffed catheters inserted through a subclavian
vein is commonly used even though ventricular tachy-
cardia secondary to fracture and embolization of the
Port-A catheter has been occasionally portrayed as a
serious complication.8 Frequent use of central venous
access systems to manage regimens for cancer patients
has increased the incidence of catheter-associated
deep venous thrombosis.9 Furthermore, pulmonary
embolism was reported in 2.5% of patients with sub-
clavian vein thrombosis.10 Potential risk factors asso-
ciated with thrombosis formation include catheter
positioning, size of the catheter, and specific site of
catheter insertion.11
As thrombus forms, treatment options may vary,
including supportive therapy, anticoagulation, catheter-
directed thrombolysis, surgical intervention to remove
intravascular clots, or revise the anatomy of the cos-
toclavicular space. Some of the published literature
suggest that whenever an indwelling central venous
catheter is indicated, an appropriate pharmacologic
agent should be initiated (i.e., low-molecular-weight
heparin, a low dose of unfractionated heparin or war-
farin) to prevent the possibility of a coagulation prob-
lem. Indeed, starting aggressive treatment as early as
possible is practicable, for active patients may decrease
patients’ long-term morbidity. Therefore, the key point
in this discussion relates to how rapidly and accurately
a clinical diagnosis can be made.
The accurate diagnosis of catheter-associated deep
venous thrombosis can, at times, be rather difficult.
The diagnosis is usually based on a patient’s clinical
history and the results of Doppler ultrasonography or
contrast venography. However, for patients with symp-
tomatic venous thrombosis, Doppler ultrasonography
would appear to have a lower accuracy as regards
diagnosis than does contrast venography. CT or 
MRI may be effective for the diagnosis of catheter-
associated deep venous thrombosis,7 but these diag-
nostic modalities are typically expensive as a routine
diagnostic tool. Contrast venography also has several
dangerous complications such as extravasation of 
the contrast medium,12 anaphylactoid reactions,13 and 
contrast-induced nephropathy.14 In vitro-labeled plate-
let scintigraphy provides direct evidence of active or
acute thrombosis.15 Unfortunately, this technique
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Table 1. Baseline characteristics and observational results of study patients
Gender
Age 
Cancer Location* 
Scintigraphic 
Comments
(yr) diagnosis
1 Male 44 Oral cancer Right subclavian vein Partial obstruction
2 Male 55 Oral cancer Left subclavian vein Partial obstruction
3 Female 64 Ovarian cancer Left subclavian vein Total occlusion Collateral circulation
4 Male 35 Esophageal cancer Right subclavian vein Patency
5 Male 44 Esophageal cancer Right subclavian vein Total occlusion Retrograde flow to jugular veins
6 Male 53 Esophageal cancer Left subclavian vein Total occlusion Venous shunt to pulmonary vessels
7 Male 61 Lung cancer Left subclavian vein Total occlusion Collateral circulation
8 Male 65 Lung cancer Left subclavian vein Total occlusion Collateral circulation
9 Male 73 Lung cancer Left subclavian vein Patency
10 Male 78 Lung cancer Left subclavian vein Partial obstruction
11 Male 69 Colon cancer Left subclavian vein Total occlusion Collateral circulation
Retrograde flow to jugular veins
12 Female 70 Colon cancer Left subclavian vein Total occlusion Collateral circulation
13 Male 71 Bladder cancer Left subclavian vein Total occlusion
14 Female 34 Lymphoma Right subclavian vein Patency
*Location, site of the Port-A catheter implantation.
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requires a labor-intensive, lengthy labeling process and
has a high number of false-negative results in patients
receiving heparin therapy.
Radionuclide venography using Tc-99m MAA is
limited in that it relies on alterations in the normal
venous anatomy. Therefore, it provides indirect evi-
dence of deep vein thrombosis and cannot differentiate
between acute and chronic deep venous thrombosis.
Nevertheless, upper extremity radionuclide venography
using Tc-99m MAA remains a practical and noninva-
sive imaging procedure for patients with Port-A
catheter thrombosis.16
In most of the published studies, venous throm-
bosis was investigated by contrast or digital subtraction
venography and Doppler ultrasonography. Celiker 
et al17 examined the role of radionuclide venography
in the diagnosis of abnormal subclavian venous flow
due to permanent pacemaker leads. Their findings
demonstrated radionuclide venography imaging pat-
terns similar to ours, even though the emphasis was
on the effect of the body diameter of the leads and 
silicone-insulated leads. Another significant difference
between our studies is that Celiker et al used Tc-99m
pertechnetate for the radiotracer and we used Tc-99m
MAA. A nuclear medicine flow study using isotope-
labeled particles (Tc-99m MAA) can be used effectively
to clearly demonstrate venous return from the upper
extremities, subclavian veins, superior vena cava, right
heart, and subsequent distribution to both lung fields.
As a consequence of one of the physical properties,
Tc-99m MAA will be trapped within the capillary
beds of the lungs, allowing a clear resultant diagnostic
image without interruption by arterial radioactivity.
In addition, the lung perfusion scan derived from 
the supplemental benefit of Tc-99m MAA could 
be acquired to verify the possibility of pulmonary
embolism.18 Although we did not acquire images 
of lung perfusion scintigraphy in the current stage,
further studies to enroll more cancer patients with
Port-A catheters could be designed to validate our
observational findings using upper extremity radio-
nuclide venography and lung perfusion scintigraphy
concurrently. 
According to the diagnostic criteria for deep venous
thrombosis using radionuclide venography, the rapid
cut-off phenomenon of radiotracer flow is one of the
major signs of thrombosis formation. Other signifi-
cant signs, the development of collateral circulation
and retrograde flow, may provide further information,
which could be helpful for the accurate diagnosis 
of deep venous thrombosis. A comparison of blood
flow in bilateral upper extremities is necessary for the
accurate diagnosis of deep venous thrombosis using
radionuclide venography. A resultant picture of the
significantly delayed passage of radiotracer and the
reduced clarity of its presence in the venous system
without truncation are considered to be partial obstruc-
tion of the venous system. A normal picture for upper
extremity radionuclide venography should reveal bilat-
eral, symmetric, rapid, and smooth radiolabeled radio-
tracer flow from the upper extremities to the central
venous system.
Upper extremity radionuclide venography is a
cost-effective imaging examination. Its nominal cost
for a patient in Taiwan is almost 1-third to half that 
of contrast venography. Radionuclide venography is
also simple and safer in terms of mortality and mor-
bidity. Another attraction for scintigraphy is its lower
radiation burden for both operators and patients. The
whole-body dose is 0.015 rad/mCi.17 The radiation
dose is a significant point if it is necessary to repeat the
procedure. Mild or even moderate stenosis, if expected
to exist on one side, could be missed. However, if our
technique using a large-field-of-view gamma camera
is applied, the detection of this degree of stenosis is
possible by comparing with the normal flow on the
other side.6,19
In conclusion, upper extremity radionuclide venog-
raphy may be used as a noninvasive and cost-effective
method, which is easily and safely performed with low
radiation exposure (total dosage less than 10 mCi) to
show the venous flow abnormalities in patients with
Port-A catheters. In particular, physicians who are not
specialists in medical imaging can easily interpret the
scintigraphic results of radionuclide venography. The
results of this investigation are helpful as a clinically
effective diagnostic approach to the presence of Port-A
catheter thrombosis. Therefore, we suggest that radio-
nuclide venography be routinely recommended for
diagnosing Port-A catheter thrombosis.
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